在Wistar大鼠中,多克索鲁比治疗对多巴胺释放和冲动行为随着时间的推移产生双相效应
Kiersten J Garcia1,2, Jacob T Theismann1,2, Tadd D Schneider3
1Ralph N. Adams Institute for Bioanalytical Chemistry, Lawrence, KS, 66047, USA.
Naunyn-Schmiedeberg's archives of pharmacology
|January 17, 2025
概括
多克索鲁比 (Dox) 化疗改变了多巴胺的释放,最初增加了多巴胺和冲动性,然后随着更长时间的治疗而降低了多巴胺活性. 这种对多巴胺系统和行为的双相效应是一个新的发现.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 在瘤学瘤学.
背景情况:
- 多克索鲁比 (Dox) 是一种广泛用于治疗各种癌症的化疗药物.
- 多克索鲁比治疗与认知障碍有关.
- 德克斯对多巴胺系统的神经化学和行为影响尚未完全理解.
研究的目的:
- 研究Dox治疗对大鼠多巴胺释放和吸收的影响.
- 评估Dox治疗的行为后果,特别是冲动性和注意力的变化.
- 阐明多克斯对多巴胺系统的双相影响.
主要方法:
- 鼠每周接受静脉注射Dox (2.5毫克/公斤) 两周或四周.
- 使用快速扫描循环电压测量 (FSCV) 在脑切片中测量多巴胺释放和吸收.
- 行为测试使用了5个选择串行反应定时任务 (5CSRTT) 来评估注意力和冲动性.
主要成果:
- 与对照组相比,两周的Dox治疗显著增加了多巴胺的释放和吸收.
- 四周后,多巴胺释放量下降到控制水平以下,而吸收量保持不变.
- 多克斯治疗在第二周和第三周增加了冲动性,但在第四周没有增加;注意力没有受到影响.
结论:
- 短期的多克斯治疗可能会增强多巴胺系统活性和冲动性.
- 长期使用Dox似乎会导致多巴胺系统的低活性.
- 这项研究揭示了多克索鲁比的新型双相神经化学和行为效应.
相关概念视频
Desensitization and Tachyphylaxis
3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Drugs Affecting Neurotransmitter Synthesis
2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K


